The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.
Open accessAbstract
Islet amyloid polypeptide (IAPP), a putative polypeptide hormone, is a product of pancreatic beta-cells and the major constituent of the amyloid deposits seen mainly in islets of type 2 diabetic humans and diabetic cats. The connection between IAPP amyloid formation and diabetes is unknown, but a limited segment of the IAPP molecule, positions 20-29, seems responsible for the aggregation to fibrils. Differences in the amino acid sequence of this region probably determine whether or not islet amyloid can develop in a particular species. Amyloid fibril formation can be mimicked in vitro with the aid of synthetic peptides. With this technique we show that peptides corresponding to IAPP positions 20-29 of human and cat, species that develop IAPP-derived islet amyloid, form amyloid-like fibrils in vitro. The corresponding IAPP segment from three rodent species that do not develop IAPP-derived amyloid did not give rise to fibrils. Substitution of the human IAPP-(20-29) decapeptide with one or two amino acid residues from species without islet amyloid generally reduced the capacity to form fibrils. We conclude that the sequence Ala-Ile-Leu-Ser-Ser, corresponding to positions 25-29 of human IAPP, is strongly amyloidogenic and that a proline-for-serine substitution in position 28, as in several rodents, almost completely inhibits formation of amyloid fibrils.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Garnier, J., Osguthorpe, D. J., & Robson, B. (1978) · Journal of Molecular Biology · doi:10.1016/0022-2836(78)90297-8 · Cited by 4,523
Empirical Predictions of Protein Conformation
Chou, P. Y., & Fasman, G. D. (1978) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.47.070178.001343 · Cited by 3,099
Prediction of the Secondary Structure of Proteins from their Amino Acid Sequence
Chou, P. Y., & Fasman, G. D. (1979) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470122921.ch2 · Cited by 2,917
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
Westermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D., & Johnson, K. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3881 · Cited by 976
Self-citationWestermark, P., Wernstedt, C., Wilander, E., & Sletten, K. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90708-4 · Cited by 510
Self-citationLukinius, A., Wilander, E., Westermark, G. T., Engstr�m, U., & Westermark, P. (1989) · Diabetologia · doi:10.1007/bf00285291 · Cited by 371
Self-citationCooper, G. J. S., Leighton, B., Dimitriadis, G., Parry‐Billings, M., Kowalchuk, J. M., Howland, K., Rothbard, J. B., Willis, A. C., & Reid, K. B. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7763 · Cited by 351
Prediction of chain turns in globular proteins on a hydrophobic basis
Rose, G. D. (1978) · Nature · doi:10.1038/272586a0 · Cited by 329
The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus
Westermark, P., & Wilander, E. (1978) · Diabetologia · doi:10.1007/bf01219652 · Cited by 291
Self-citation
Cited by
Sorted by citations
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
A possible role for π‐stacking in the self‐assembly of amyloid fibrils
Gazit, E. (2002) · The FASEB Journal · doi:10.1096/fj.01-0442hyp · Cited by 1,128
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044
Self-citationIncreased Risk of Type 2 Diabetes in Alzheimer Disease
Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950
Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
Lorenzo, A., Razzaboni, B. L., Weir, G. C., & Yankner, B. A. (1994) · Nature · doi:10.1038/368756a0 · Cited by 820
The Importance of -Cell Failure in the Development and Progression of Type 2 Diabetes
Kahn, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7713 · Cited by 710
Janson, J., Ashley, R. H., Harrison, D. J., McIntyre, S., & Butler, P. C. (1999) · Diabetes · doi:10.2337/diabetes.48.3.491 · Cited by 614
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
Haataja, L., Gurlo, T., Huang, C. J., & Butler, P. C. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0037 · Cited by 624
Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes
Hull, R. L., Westermark, G. T., Westermark, P., & Kahn, S. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0405 · Cited by 592
Self-citationAggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease
Hilbich, C., Kisters–Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. T. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90881-6 · Cited by 580
Luca, S., Yau, W., Leapman, R. D., & Tycko, R. (2007) · Biochemistry · doi:10.1021/bi701427q · Cited by 584
Islet amyloid and type 2 diabetes mellitus.
Höppener, J., Bo, A.-R., & Lips, C. J. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008103430607 · Cited by 499
van Rossum, D., Hanisch, U., & Quirion, R. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00023-1 · Cited by 517
Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease
Adams, D., Koike, H., Slama, M., & Coelho, T. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0210-4 · Cited by 469
Tenidis, K., Waldner, M., Bernhagen, J., Fischle, W., Bergmann, M., Weber, M., Merkle, M.-L., Voelter, W., Brunner, H., & Kapurniotu, A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3422 · Cited by 401
Seeding Specificity in Amyloid Growth Induced by Heterologous Fibrils
O’Nuallain, B., Williams, A. D., Westermark, P., & Wetzel, R. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311300200 · Cited by 422
Self-citationAnalysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide
Rosenfeld, R., & Gazit, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102883200 · Cited by 421
Proline and Glycine Control Protein Self-Organization into Elastomeric or Amyloid Fibrils
Rauscher, S., Baud, S., Miao, M., Keeley, F. W., & Pomès, R. (2006) · Structure · doi:10.1016/j.str.2006.09.008 · Cited by 374
A Molecular Model of Alzheimer Amyloid β-Peptide Fibril Formation
Tjernberg, L. O., Callaway, D. J. E., Tjernberg, A., Hahne, S., Lilliehöök, C., Terenius, L. Y., Thyberg, J., & Nordstedt, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12619 · Cited by 360
Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in Vitro
Kayed, R., Bernhagen, J., Greenfield, N. J., Sweimeh, K., Brunner, H., Voelter, W., & Kapurniotu, A. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2646 · Cited by 351
Zhao, W.-Q., & Townsend, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.014 · Cited by 291
Type 2 diabetes as a protein misfolding disease
Mukherjee, A., Morales‐Scheihing, D., Butler, P. C., & Soto, C. A. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.04.005 · Cited by 349
Soluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases
Ferreira, S. T., Vieira, M. N. N., & De Felice, F. G. (2007) · IUBMB Life · doi:10.1080/15216540701283882 · Cited by 335
Watching amyloid fibrils grow by time-lapse atomic force microscopy 1 1Edited by W. Baumeister
Goldsbury, C. S., Kistler, J., Aebi, U., Arvinte, T., & Cooper, G. J. S. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2299 · Cited by 324
Atomic structure of the cross‐β spine of islet amyloid polypeptide (amylin)
Wiltzius, J. J. W., Sievers, S. A., Sawaya, M. R., Cascio, D., Popov, D., Riekel, C., & Eisenberg, D. S. (2008) · Protein Science · doi:10.1110/ps.036509.108 · Cited by 326
Amyloid Fibril Formation from Full-Length and Fragments of Amylin
Goldsbury, C. S., Goldie, K. N., Pellaud, J., Seelig, J., Frey, P., Müller, S. A., Kistler, J., Cooper, G. J. S., & Aebi, U. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4268 · Cited by 316
Prolines and Aamyloidogenicity in Fragments of the Alzheimer's Peptide .beta./A4
Wood, S. J., Wetzel, R. B., Martin, J. D., & Hurle, M. R. (1995) · Biochemistry · doi:10.1021/bi00003a003 · Cited by 313
Conserved and Cooperative Assembly of Membrane-Bound α-Helical States of Islet Amyloid Polypeptide
Knight, J. D., Hebda, J. A., & Miranker, A. D. (2006) · Biochemistry · doi:10.1021/bi060579z · Cited by 310
Akkermans, C., Venema, P., van der Goot, A. J., Gruppen, H., Bakx, E. J., Boom, R. M., & van der Linden, E. (2008) · Biomacromolecules · doi:10.1021/bm7014224 · Cited by 304
Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology
Jaikaran, E. T. A. S., & Clark, A. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00078-3 · Cited by 298
Fowler, S. A., & Blackwell, H. E. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b817980h · Cited by 294
Shim, S., Gupta, R., Ling, Y. L., Strasfeld, D. B., Raleigh, D. P., & Zanni, M. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805957106 · Cited by 286
Mechanism of IAPP amyloid fibril formation involves an intermediate with a transient β-sheet
Buchanan, L. E., Dunkelberger, E. B., Tran, H. Q., Cheng, P.-N., Chiu, C.-C., Cao, P., Raleigh, D., de Pablo, J. D., Nowick, J., & Zanni, M. (2013) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1314481110 · Cited by 251
Islet amyloid polypeptide: structure, function, and pathophysiology
Akter, R., Cao, P., Noor, H., Ridgway, Z., Tu, L.-H., Wang, H., Wong, A. G., Zhang, X., Abedini, A., Schmidt, A. M., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2798269 · Cited by 273
Butler, A. E., Jang, J., Gurlo, T., Carty, M. D., Soeller, W. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1509 · Cited by 267
Fu, L., Liu, J., & Yan, E. C. Y. (2011) · Journal of the American Chemical Society · doi:10.1021/ja201575e · Cited by 261
Sparr, E., Engel, M. F. M., Sakharov, D. V., Sprong, M., Jacobs, J., KRUIJFF, B. D., Höppener, J. W. M., & Killian, J. A. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.075 · Cited by 257
Thioflavine T interaction with amyloid β-sheet structures
LeVine, H. (1995) · Amyloid · doi:10.3109/13506129509031881 · Cited by 254
Mechanisms of amyloid fibril self‐assembly and inhibition
Gazit, E. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.05022.x · Cited by 248
Amylin Agonists: A Novel Approach in the Treatment of Diabetes
Schmitz, O., Brock, B., & Rungby, J. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s233 · Cited by 237
Jaikaran, E. T. A. S., Higham, C. E., Serpell, L. C., Zurdo, J., Gross, M., Clark, A., & Fraser, P. E. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4593 · Cited by 236
Khemtémourian, L., Killian, J. A., Höppener, J. W. M., & Engel, M. F. M. (2008) · Journal of Diabetes Research · doi:10.1155/2008/421287 · Cited by 238
Brender, J., Lee, E. L., Cavitt, M. A., Gafni, A., Steel, D. G., & Ramamoorthy, A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja710484d · Cited by 229
Porat, Y., Mazor, Y., Efrat, S., & Gazit, E. (2004) · Biochemistry · doi:10.1021/bi048582a · Cited by 228
Hebda, J. A., & Miranker, A. D. (2009) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.050708.133622 · Cited by 223
Advanced Luminescent Materials Based on Organoboron Polymers
Tanaka, K., & Chujo, Y. (2012) · Macromolecular Rapid Communications · doi:10.1002/marc.201200239 · Cited by 223
Dupuis, N., Wu, C. F., Shea, J., & Bowers, M. T. (2009) · Journal of the American Chemical Society · doi:10.1021/ja903814q · Cited by 215
Zraika, S., Hull, R. L., Udayasankar, J., Aston‐Mourney, K., Subramanian, S. L., Kisilevsky, R., Szarek, W. A., & Kahn, S. E. (2009) · Diabetologia · doi:10.1007/s00125-008-1255-x · Cited by 215
Direct detection of transient α‐helical states in islet amyloid polypeptide
Williamson, J. A., & Miranker, A. D. (2006) · Protein Science · doi:10.1110/ps.062486907 · Cited by 215
Yates, S. L., Burgess, L. H., Kocsis‐Angle, J., Antal, J. M., Dority, M. D., Embury, P. B., Piotrkowski, A. M., & Brunden, K. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741017.x · Cited by 202
Mechanisms of islet amyloidosis toxicity in type 2 diabetes
Abedini, A., & Schmidt, A. M. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.017 · Cited by 206
Islet amyloid polypeptide and type 2 diabetes.
Marzban, L., Park, K., & Verchere, C. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00004-4 · Cited by 191
Milardi, D., Gazit, E., Radford, S. E., Xu, Y., Gallardo, R. U., Caflisch, A., Westermark, G. T., Westermark, P., Rosa, C. L., & Ramamoorthy, A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00981 · Cited by 199
Self-citationCefalu, W. T. (2006) · ILAR Journal · doi:10.1093/ilar.47.3.186 · Cited by 206
Madine, J., Jack, E. R., Stockley, P. G., Radford, S. E., Serpell, L. C., & Middleton, D. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja802483d · Cited by 195
Correia, S. C., Santos, R. X., Carvalho, C., Cardoso, S., Candeias, E., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2012) · Brain Research · doi:10.1016/j.brainres.2011.12.063 · Cited by 202
Panda, J. J., & Chauhan, V. S. (2014) · Polymer Chemistry · doi:10.1039/c4py00173g · Cited by 195
The Parallel Superpleated Beta-structure as a Model for Amyloid Fibrils of Human Amylin
Kajava, A. V., Aebi, U., & Steven, A. C. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.02.029 · Cited by 191
Young, L. M., Cao, P., Raleigh, D. P., Ashcroft, A. E., & Radford, S. E. (2013) · Journal of the American Chemical Society · doi:10.1021/ja406831n · Cited by 190
Mazor, Y., Gilead, S., Benhar, I., & Gazit, E. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00887-2 · Cited by 186
Williamson, J. A., Loria, J. P., & Miranker, A. D. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.07.077 · Cited by 186
Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?
Clark, A., & Nilsson, M. R. (2004) · Diabetologia · doi:10.1007/s00125-003-1304-4 · Cited by 191
Apostolidou, M., Jayasinghe, S. A., & Langen, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801383200 · Cited by 184
Lin, C., Gurlo, T., Kayed, R., Butler, A. E., Haataja, L., Glabe, C. G., & Butler, P. C. (2007) · Diabetes · doi:10.2337/db06-1579 · Cited by 183
Effects of in vivo conditions on amyloid aggregation
Owen, M. C., Gnutt, D., Gao, M., Wärmländer, S. K. T. S., Jarvet, J., Gräslund, A., Winter, R., Ebbinghaus, S., & Strodel, B. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00034d · Cited by 181
Fu, L., Ma, G., & Yan, E. C. Y. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909546b · Cited by 181
Zraika, S., Hull, R. L., Verchere, C. B., Clark, A., Potter, K. J., Fraser, P. E., Raleigh, D. P., & Kahn, S. E. (2010) · Diabetologia · doi:10.1007/s00125-010-1671-6 · Cited by 191
Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-β fibrils
Röder, C., Kupreichyk, T., Gremer, L., Schäfer, L. U., Pothula, K. R., Ravelli, R. B. G., Willbold, D., Hoyer, W., & Schröder, G. F. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0442-4 · Cited by 180
Islet amyloid: From fundamental biophysics to mechanisms of cytotoxicity
Cao, P., Marek, P., Noor, H., Patsalo, V., Tu, L., Wang, H., Abedini, A., & Raleigh, D. P. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.046 · Cited by 178
Human IAPP–induced pancreatic β cell toxicity and its regulation by autophagy
Shigihara, N., Fukunaka, A., Hara, A., Komiya, K., Honda, A., Uchida, T., Abe, H., Toyofuku, Y., Tamaki, M., Ogihara, T., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69866 · Cited by 177
Membrane interaction of islet amyloid polypeptide
Jayasinghe, S. A., & Langen, R. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.01.022 · Cited by 181
Kapurniotu, A., Schmauder, A., & Tenidis, K. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5244 · Cited by 173
Islet Amyloid Polypeptide Inserts into Phospholipid Monolayers as Monomer
Engel, M. F. M., Yigittop, H., Elgersma, R. C., Rijkers, D. T. S., Liskamp, R. M. J., KRUIJFF, B. D., Höppener, J. W. M., & Killian, J. A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.12.020 · Cited by 174
Structures of Rat and Human Islet Amyloid Polypeptide IAPP1−19 in Micelles by NMR Spectroscopy
Nanga, R. P. R., Brender, J., Xu, J., Veglia, G., & Ramamoorthy, A. (2008) · Biochemistry · doi:10.1021/bi8014357 · Cited by 172
The structure and mechanism of formation of human calcitonin fibrils.
Arvinte, T., Cudd, A., & Drake, A. F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53268-3 · Cited by 172
Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts
Potter, K. J., Abedini, A., Marek, P., Klimek-Abercrombie, A. M., Butterworth, S. A., Driscoll, M., Baker, R. L., Nilsson, M. R., Warnock, G. L., Oberholzer, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909024107 · Cited by 171
Degradation of Amylin by Insulin-degrading Enzyme
Bennett, R. G., Duckworth, W. C., & Hamel, F. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006170200 · Cited by 170
Atrián‐Blasco, E., Gonzalez, P., Santoro, A., Aliès, B., Faller, P., & Hureau, C. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.04.007 · Cited by 175
Missense Mutation of Amylin Gene (S20G) in Japanese NIDDM Patients
Sakagashira, S., Sanke, T., Hanabusa, T., Shimomura, H., Ohagi, S., Kumagaye, K. Y., Nakajima, K., & Nanjo, K. (1996) · Diabetes · doi:10.2337/diab.45.9.1279 · Cited by 162
Proinsulin maturation, misfolding, and proteotoxicity
Liu, M. R., Hodish, I., Rhodes, C. J., & Arvan, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702697104 · Cited by 159
Green, J. D., Kreplak, L., Goldsbury, C. S., Li‐Blatter, X., Stolz, M., Cooper, G. J. S., Seelig, A., Kistler, J., & Aebi, U. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.07.052 · Cited by 161
Abedini, A., Plesner, A., Cao, P., Ridgway, Z. M., Zhang, J., Tu, L., Middleton, C. T., Chao, B., Sartori, D. J., Meng, F., et al. (2016) · eLife · doi:10.7554/elife.12977 · Cited by 160
Höppener, J. W. M., Oosterwijk, C., Nieuwenhuis, M. G., Posthuma, G., Thijssen, J. H. H., Vroom, T. M., Ahrén, B., & Lips, C. J. M. (1999) · Diabetologia · doi:10.1007/s001250051175 · Cited by 153
Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes
Kim, J., Cheon, H., Jeong, Y. T., Quan, W., Kim, K. H., Cho, J. M., Lim, Y.-M., Oh, S. H., Jin, S., Kim, J. H., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69625 · Cited by 159
Ancsin, J. B. (2003) · Amyloid · doi:10.3109/13506120309041728 · Cited by 158
Jayasinghe, S. A., & Langen, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406853200 · Cited by 153
Pike, C. J., Cummings, B. J., Monzavi, R., & Cotman, C. W. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90547-9 · Cited by 157
Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin
Srodulski, S. J., Sharma, S., Bachstetter, A. D., Brelsfoard, J., Pascual, C., Xie, X., Saatman, K. E., Eldik, L. J. V., & Despa, F. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-30 · Cited by 159
Islet Amyloid Polypeptide (IAPP) Transgenic Rodents as Models for Type 2 Diabetes
Matveyenko, A. V., & Butler, P. C. (2006) · ILAR Journal · doi:10.1093/ilar.47.3.225 · Cited by 150
Inhibition of Amyloid Fibril Formation by Peptide Analogues Modified with α‐Aminoisobutyric Acid
Gilead, S., & Gazit, E. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353565 · Cited by 147
Casas, S., Gomis, R., Gribble, F. M., Altirriba, J., Knuutila, S., & Novials, A. (2007) · Diabetes · doi:10.2337/db07-0178 · Cited by 148
Nanga, R. P. R., Brender, J., Xu, J., Hartman, K. L., Vivekanandan, S., & Ramamoorthy, A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9010095 · Cited by 147
Structural Characterisation of Islet Amyloid Polypeptide Fibrils
Makin, O. S., & Serpell, L. C. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.11.048 · Cited by 147
Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils
Johan, K., Westermark, G. T., Engström, U., Gustavsson, Å., Hultman, P. A., & Westermark, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2558 · Cited by 147
Self-citationNilsson, M. R., & Raleigh, D. P. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3286 · Cited by 146
Role of islet amyloid in type 2 diabetes mellitus
Höppener, J. W. M., & Lips, C. J. M. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.12.009 · Cited by 148
Design of Peptide-based Inhibitors of Human Islet Amyloid Polypeptide Fibrillogenesis
Scrocchi, L. A., Chen, Y., Waschuk, S., Wang, F., Cheung, S., Darabie, A. A., McLaurin, J., & Fraser, P. E. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00164-x · Cited by 143
Inhibition of IAPP and IAPP(20−29) Fibrillation by Polymeric Nanoparticles
Cabaleiro-Lago, C., Lynch, I., Dawson, K. A., & Linse, S. S. (2009) · Langmuir · doi:10.1021/la902980d · Cited by 142
Metadata
- Authors
- Westermark, P., Engström, U., Johnson, K. H., Westermark, G. T., & Betsholtz, C.
- Affiliations
- Linköping University Hospital (SE)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1990-07
- Volume
- 87
- Issue
- 13
- Pages
- 5036-5040
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC54256
- OpenAlex
- W2061111679
- Cited by
- 807
- References
- 30
- Citations by year
- 2026: 18 · 2025: 20 · 2024: 27 · 2023: 17 · 2022: 25 · 2021: 31 · 2020: 43 · 2019: 21 · 2018: 28 · 2017: 41 · 2016: 36 · 2015: 36 · 2014: 29 · 2013: 33 · 2012: 36
- FWCI
- 7.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk036734-06)
- Medical Research Council
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK36734)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- amylin, amyloid fibril formation, type 2 diabetes, pancreatic beta cells, peptide aggregation
- MeSH terms
- Amino Acid Sequence, Amyloid, Amyloidosis, Animals, Cats, Diabetes Mellitus, Type 2, Cricetinae, Humans, Islets of Langerhans, Microscopy, Electron, Molecular Sequence Data, Mutation, Protein Precursors, Sequence Homology, Nucleic Acid, Species Specificity, Rats, Islet Amyloid Polypeptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review